Education and innovation were they keys to this year's MM&M Awards in the consumer marketing and advertising categories as the judges rewarded brains over mere branding.

Nimble smaller shops triumphed alongside the heavyweights at tonight's MM&M Awards, while device and diagnostics makers muscled past pharma competitors in several categories.

The FDA's Division of Drug Marketing, Advertising and Communications issued an "untitled/notice of violation" letter on a patient brochure for Amgen's Sensipar, which is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.

A new training effort aims to help medical education faculty distinguish between certified and promotional CME.

GlaxoSmithKline plans to disclose payments to US physicians and impose a cap of $150,000 per year, per doctor, but details of the disclosure scheme are still being worked out.

Pfizer reported static third quarter revenues of $12 billion, with solid international sales offsetting weaker US sales for several key products.

Novartis will eliminate 550 positions from its US sales force "in a socially responsible manner," with half coming from unfilled vacancies, and establish five new regional units with cross-functional responsibility for primary care as part of its "Customer Centric Initiative."

Acne and adult ADHD sufferers are the condition groups most likely to watch their favorite TV shows online, according to a Manhattan Research survey.

Reps. John Dingell and Bart Stupak (both D-MI) wrote the FDA to question its use of a pharma PR firm in developing a website about DTC advertising for consumers.

J&J flaunted the benefits of its diversified and globalized business portfolio today, reporting respectable third-quarter results despite static worldwide pharmaceutical sales of $6.1 billion.